Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Recursion Pharmaceuticals A | RXRX | Jan 21, 2025 | 6.88 | +5.36 |
Red Cat | RCAT | Jan 21, 2025 | 8.46 | -1.11 |
Red River Bancshares | RRBI | Jan 21, 2025 | 52.39 | -0.66 |
Red Robin Gourmet Burgers | RRGB | Jan 21, 2025 | 5.72 | +2.88 |
Red Rock Resorts A | RRR | Jan 21, 2025 | 47.54 | +1.73 |
Red Violet | RDVT | Jan 21, 2025 | 35.64 | +0.54 |
RDDT | Jan 21, 2025 | 188.32 | +7.41 | |
Redfin | RDFN | Jan 21, 2025 | 7.80 | +1.43 |
RedHill Biopharma ADR | RDHL | Jan 21, 2025 | 6.33 | +12.30 |
Redwire | RDW | Jan 21, 2025 | 22.33 | +51.39 |
Redwood Trust | RWT-A | Jan 21, 2025 | 25.73 | +1.70 |
Redwood Trust | RWT | Jan 21, 2025 | 6.42 | -1.23 |
REE Automotive A | REE | Jan 21, 2025 | 8.76 | -0.45 |
Regal Rexnord | RRX | Jan 21, 2025 | 162.06 | +3.55 |
Regency Centers | REG | Jan 21, 2025 | 71.96 | +1.04 |
Regency Centers A Pref | REGCP | Jan 21, 2025 | 23.54 | +1.20 |
Regency Centers B Pref | REGCO | Jan 21, 2025 | 22.32 | -2.11 |
Regeneron Pharmaceuticals | REGN | Jan 21, 2025 | 687.80 | +0.91 |
REGENXBIO | RGNX | Jan 21, 2025 | 7.57 | +2.71 |
Regional Health Properties | RHE | Jan 21, 2025 | 2.85 | +24.45 |
Regional Health Properties A Pref | RHE-A | Jan 21, 2025 | 0.83 | +5.98 |
Regional Management | RM | Jan 21, 2025 | 35.67 | -0.06 |
Regions Financial | RF | Jan 21, 2025 | 24.65 | +1.86 |
Regions Financial B Pref | RF-B | Jan 21, 2025 | 24.98 | 0.00 |
Regions Financial C Pref | RF-C | Jan 21, 2025 | 24.80 | -0.04 |
Regions Financial E Pref | RF-E | Jan 21, 2025 | 18.50 | +2.04 |
Regions Finl New Dep Shs Repstg 1100th Perp Pfd Ser F | RF-F | Jan 21, 2025 | 25.66 | +0.27 |
Regis | RGS | Jan 21, 2025 | 23.71 | -3.22 |
Regulus Therapeutics | RGLS | Jan 21, 2025 | 1.26 | +1.61 |
Rein Therapeutics | RNTX | Jan 21, 2025 | 1.94 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.